Anti-inflammatory use during surgery could improve cancer outcomes
Tuesday, September 4, 2018 - 10:42
in Health & Medicine
The world's first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in colon cancer patients to improve their cancer outcome.